Increased ROS levels were found in several studies using cellular models and post-mortem tissues from SMA patients, both before and after the beginning of SMA symptoms [37,38,39], and NRF2 plays a pivotal role in ROS regulation. This evidence concerns the gene NFE2L2 and proximal spinal muscular atrophy.